The San Diego Primary Infection Resource Consortium (PIRC) R24 application represents an opportunity to sustain more than 16 years of remarkably productive collaborative research related to the identification and recruitment of persons with acute and early HIV (AEH) infection from the San Diego community. Using novel and evolving methods to recruit persons with AEH, we have established extensive infrastructure and community support to test 3,600 individuals annually using dual point-of-care HIV rapid test (RT) screening, paired with HIV nucleic acid testing (NAT) in all RT negative persons. The projected HIV screening program will ensure the identification and recruitment of 45 AEH, 40 chronic HIV (C-HIV), 40 sexual partners (SP) of participants with AEH (both transmitting and non-transmitting) and 120 repeatedly-exposed, HIV uninfected (EU-HIV) individuals each year. From these participants, vve propose to collect, process, cryostore, and make available a variety of biological specimens (depending on stage of HIV infection), including blood plasma, peripheral blood mononuclear cells (PBMC), genital secretions, rectal swabs, and oral fluid. We also record extensive demographic, behavioral, and risk data that are linked to participants and their stored specimens. The PIRC proposes to offer access to both archived and prospective resources using a multi- institutional review of concept sheet research proposals submitted by eligible consortium investigators. In order to provide access to richly annotated data and specimens and to enable prospective basic, translational, epidemiologic, and modeling research, the PIRC will address the following Specific Aims: 1) Program oversight and research access to PIRC;2) Identify, enroll, and retain a cohort representative of the San Diego HlV epidemic and suitable for accurate inference of transmission dynamics;3) Collect clinical and behavioral information, and biological samples from piRC participants;4) Provide integrated, flexible and accessible data management and information technology guidance and support;and 5) Provide statistical and network modeling expertise. The PIRC will provide a sophisticated online data storage and retrieval system that will facilitate concept sheet submission and data access for consortium investigators.

Public Health Relevance

The San Diego Primary Infection Resource Consortium (PIRC) will provide extensive clinical and behavioral data, biological materials, open source software tools, and services that are of high quality and cost-efficient. The breadth of the collected data will represent a significant opportunity for consortium investigators to evaluate pressing issues related to HIV transmission, prevention, resistance, superinfection, and eradication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Resource-Related Research Projects (R24)
Project #
1R24AI106039-01
Application #
8510795
Study Section
Special Emphasis Panel (ZAI1-DR-A (J1))
Program Officer
Mckaig, Rosemary G
Project Start
2013-08-20
Project End
2017-07-31
Budget Start
2013-08-20
Budget End
2014-07-31
Support Year
1
Fiscal Year
2013
Total Cost
$1,430,884
Indirect Cost
$426,709
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Chin, Bum Sik; Kim, Jae Yoon; Gianella, Sara et al. (2016) Travel Pattern and Prescription Analysis at a Single Travel Clinic Specialized for Yellow Fever Vaccination in South Korea. Infect Chemother 48:20-30
Hoenigl, Martin; Chaillon, Antoine; Kessler, Harald H et al. (2016) Characterization of HIV Transmission in South-East Austria. PLoS One 11:e0151478
Yek, Christina; Gianella, Sara; Plana, Montserrat et al. (2016) Standard vaccines increase HIV-1 transcription during antiretroviral therapy. AIDS 30:2289-98
Dan, Jennifer M; Massanella, Marta; Smith, Davey M et al. (2016) Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART. J Acquir Immune Defic Syndr 72:133-7
Kassanjee, Reshma; Pilcher, Christopher D; Busch, Michael P et al. (2016) Viral load criteria and threshold optimization to improve HIV incidence assay characteristics. AIDS 30:2361-71
Yang, S; Lok, J J (2016) A goodness-of-fit test for structural nested mean models. Biometrika 103:734-741
Hoenigl, Martin; Chaillon, Antoine; Morris, Sheldon R et al. (2016) HIV Infection Rates and Risk Behavior among Young Men undergoing community-based Testing in San Diego. Sci Rep 6:25927
Mehta, Sanjay R; Murrell, Ben; Anderson, Christy M et al. (2016) Using HIV Sequence and Epidemiologic Data to Assess the Effect of Self-referral Testing for Acute HIV Infection on Incident Diagnoses in San Diego, California. Clin Infect Dis 63:101-7
Hoenigl, Martin; de Oliveira, Michelli Faria; Pérez-Santiago, Josué et al. (2016) (1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study. Medicine (Baltimore) 95:e3162
Karris, Maile Y; Jain, Sonia; Bowman, Vi Q et al. (2016) Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue. J Acquir Immune Defic Syndr 72:e48-50

Showing the most recent 10 out of 53 publications